As depicted in Fig. 7B, significantly higher levels of CXCL13 (median 250 pg/ml, ± 55 pg/ml) were detected in MM patients compared to healthy controls (median 50 pg/ml, ± 22 pg/ml), p < 0.0001. Here, CXCL13 is linked to Miyoshi myopathy.